Marian Macsai

Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ.

Northshore University Healthsystem provides healthcare services. The firm offers family, nuclear, pulmonary medicine, plastic surgery and surgical services. It also offers teaching and research programs, and trauma, prenatal and mammography centers. The company was founded in 1891 and is headquartered in Evanston, IL.

Cornea Society, Inc. is an international society that promotes the exchange of information in cornea and external disease. The non-profit company is based in San Francisco, CA. The company offers research initiatives, publications, awards, and video education to their members. The society sponsors and supports Cornea: The Journal of Cornea and External Disease, which is recognized as the journal of record of the subspecialty of cornea and external disease.